LOXL2 and breast carcinoma: Our previous studies in a large series of human tumor samples demonstrated that intracellular LOXL2 is associated with poor prognosis in laryngeal squamous-cell carcinomas and with distant metastasis in basal-like breast carcinomas [17,18].